Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6411)
All Articles published online
|
Publishing Process of This Article
|
May 6, 2014 (publication date) through Apr 16, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Konidari A, Matary WE. Use of thiopurines in inflammatory bowel disease: Safety issues. World J Gastrointest Pharmacol Ther 2014; 5(2): 63-76 [PMID: 24868487 DOI: 10.4292/wjgpt.v5.i2.63] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v5/i2/63.htm |
| Number | Citing Articles |
| 1 |
Marius Vögelin, Luc Biedermann, Pascal Frei, Stephan R. Vavricka, Sylvie Scharl, Jonas Zeitz, Michael C. Sulz, Michael Fried, Gerhard Rogler, Michael Scharl, John Green. The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease. PLOS ONE 2016; 11(5): e0155218 doi: 10.1371/journal.pone.0155218
|
| 2 |
Sherif M Hamdy, Maged Abdel-Naseer, Hatem S Shehata, Nevin M Shalaby, Amr Hassan, Alaa Elmazny, Ehab Shaker, Mona AF Nada, Sandra M Ahmed, Mohamed I Hegazy, Husam S Mourad, Ahmed Abdelalim, Rehab Magdy, Alshimaa S Othman, Doaa A Mekkawy, Nirmeen A Kishk. <p>Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era</p>. Therapeutics and Clinical Risk Management 2020; : 759 doi: 10.2147/TCRM.S261753
|
| 3 |
Elena Genova, Marianna Lucafò, Marco Pelin, Veronica Di Paolo, Luigi Quintieri, Giuliana Decorti, Gabriele Stocco. Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells. Chemico-Biological Interactions 2021; 347: 109624 doi: 10.1016/j.cbi.2021.109624
|
| 4 |
Hitomi Okamoto, Yoichi Tanaka, Yoshio Shibagaki, Satoshi Kuronuma, Yusuke Miyatani, Satoko Umeda, Emi Mishiro-Sato, Osamu Takeuchi, Seisuke Hattori, Taku Kobayashi, Mitsuru Okuwaki. Measurement of the intracellular active metabolites of thiopurine drugs to evaluate the enzymatic activity of nudix hydrolase 15 in human blood samples. Journal of Chromatography B 2024; 1234: 123993 doi: 10.1016/j.jchromb.2024.123993
|
| 5 |
Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, Yasuo Suzuki, Yoshifumi Ohnishi, Noriyuki Fujii, Nobuko Matsushima, Richuan Zheng, Colleen W. Marano. Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI). Intestinal Research 2021; 19(4): 386 doi: 10.5217/ir.2020.00080
|
| 6 |
Pieter Hindryckx, Gregor Novak. Can we move directly from 5-ASA to a biologic agent in ulcerative colitis?. Best Practice & Research Clinical Gastroenterology 2018; : 9 doi: 10.1016/j.bpg.2018.05.004
|
| 7 |
Bruce E Sands, Stefan Schreiber, Irina Blumenstein, Michael V Chiorean, Ryan C Ungaro, David T Rubin. Clinician’s Guide to Using Ozanimod for the Treatment of Ulcerative Colitis. Journal of Crohn's and Colitis 2023; 17(12): 2012 doi: 10.1093/ecco-jcc/jjad112
|
| 8 |
K. J. G. Brouwers, R. Vis, R. A. Tupker. Itraconazole as a continuous treatment for atopic dermatitis? A case report. Journal of the European Academy of Dermatology and Venereology 2016; 30(5): 873 doi: 10.1111/jdv.13040
|
| 9 |
Siddharth Singh, Edward V. Loftus, Berkeley N. Limketkai, John P. Haydek, Manasi Agrawal, Frank I. Scott, Ashwin N. Ananthakrishnan. AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Gastroenterology 2024; 167(7): 1307 doi: 10.1053/j.gastro.2024.10.001
|
| 10 |
Rishu Dheer, Julie M. Davies, Maria T. Abreu. Intestinal Tumorigenesis. 2015; : 211 doi: 10.1007/978-3-319-19986-3_8
|
| 11 |
Katarína Maráková, Juraj Piešťanský, Zuzana Zelinková, Peter Mikuš. Capillary Electrophoresis Hyphenated with Mass Spectrometry for Determination of Inflammatory Bowel Disease Drugs in Clinical Urine Samples. Molecules 2017; 22(11): 1973 doi: 10.3390/molecules22111973
|
| 12 |
Margalida Calafat, Míriam Mañosa, Fiorella Cañete, Elena Ricart, Eva Iglesias, Marta Calvo, Francisco Rodríguez‐Moranta, Carlos Taxonera, Pilar Nos, Francisco Mesonero, María-Dolores Martín‐Arranz, Miguel Mínguez, Javier P. Gisbert, Santiago García‐López, Ruth de Francisco, Fernando Gomollón, Xavier Calvet, Esther Garcia‐Planella, Montserrat Rivero, Jesús Martínez‐Cadilla, Federico Argüelles, Lara Arias, Marta Cimavilla, Yamile Zabana, Eugeni Domènech. Increased risk of thiopurine‐related adverse events in elderly patients with IBD. Alimentary Pharmacology & Therapeutics 2019; 50(7): 780 doi: 10.1111/apt.15458
|
| 13 |
Anke L. H. Nguyen, Miles P. Sparrow. Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules. Digestive Diseases and Sciences 2021; 66(10): 3250 doi: 10.1007/s10620-020-06662-z
|
| 14 |
Jill M Plevinsky, Andrea A Wojtowicz, Steven A Miller, Rachel N Greenley. Longitudinal Barriers to Thiopurine Adherence in Adolescents With Inflammatory Bowel Diseases. Journal of Pediatric Psychology 2019; 44(1): 52 doi: 10.1093/jpepsy/jsy062
|
| 15 |
Xiaoxi Cai, Wanhong Wu, Guimu Guo, Jiarui Chen, Jianwen Xu, WeiWei Lin, Pinfang Huang, Cuihong Lin, Rongfang Lin. Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of Ustekinumab in pediatric patients with inflammatory bowel disease. European Journal of Pharmaceutical Sciences 2024; 199: 106807 doi: 10.1016/j.ejps.2024.106807
|
| 16 |
Anita Annaházi, Tamás Molnár. Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/832395
|
| 17 |
Brian G. Feagan, William J. Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R. Friedman, Marion A. Blank, Jewel Johanns, Long-Long Gao, Ye Miao, Omoniyi J. Adedokun, Bruce E. Sands, Stephen B. Hanauer, Severine Vermeire, Stephan Targan, Subrata Ghosh, Willem J. de Villiers, Jean-Frédéric Colombel, Zsolt Tulassay, Ursula Seidler, Bruce A. Salzberg, Pierre Desreumaux, Scott D. Lee, Edward V. Loftus, Levinus A. Dieleman, Seymour Katz, Paul Rutgeerts. Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease. New England Journal of Medicine 2016; 375(20): 1946 doi: 10.1056/NEJMoa1602773
|
| 18 |
Cynthia Morvillo, Katherine Vinci, Lauren Hedenschoug, Leah Mancini, Carrie Mize, Kayce Tugg, Steven Stein. Risks and Safety of Advanced Therapies and Biologics in Inflammatory Bowel Disease. Gastroenterology Nursing 2020; 43(4): E159 doi: 10.1097/SGA.0000000000000523
|
| 19 |
Wael El‐Matary, Matthew W. Carroll, Jennifer C. Debruyn, Hien Huynh, Eytan Wine, Sally Lawrence, Abin Chandrakumar, Terra Morel, Kevan Jacobson. Discontinuation of Immunosuppressive Medications in Children With Inflammatory Bowel Disease on Combination Therapy. Journal of Pediatric Gastroenterology and Nutrition 2020; 71(6): 740 doi: 10.1097/MPG.0000000000002857
|
| 20 |
Ciarán McDonald, Hilary Kerr, Eimear Gibbons, Tincymol Lukose, Danny Cheriyan, Gavin Harewood, Stephen Patchett, Aoibhlinn O’Toole, Orlaith Kelly, Karen Boland. Higher Ustekinumab Levels in Maintenance Therapy are Associated with Greater Mucosal Healing and Mucosal Response in Crohn’s Disease: An Experience of 2 IBD Centers. Inflammatory Bowel Diseases 2024; 30(3): 423 doi: 10.1093/ibd/izad073
|
| 21 |
Noa Krugliak Cleveland, Alexandra Masching, David T. Rubin. Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's Disease. ACG Case Reports Journal 2020; 7(8): e00449 doi: 10.14309/crj.0000000000000449
|
| 22 |
Wael El-Matary, Charles N. Bernstein. Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease. Frontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.00400
|
| 23 |
Wael El-Matary, Stella Leung, Aruni Tennakoon, Eric I Benchimol, Charles N Bernstein, Laura E Targownik. Trends of Utilization of Tumor Necrosis Factor Antagonists in Children With Inflammatory Bowel Disease: A Canadian Population-Based Study. Inflammatory Bowel Diseases 2019; doi: 10.1093/ibd/izz157
|
| 24 |
Omar I. Saadah, Turki AlAmeel, Ahmed Al Sarkhy, Mohammed Hasosah, Abdulrahman Al-Hussaini, Majid A. Almadi, Badr Al-Bawardy, Talal A. Altuwaijri, Mohammed AlEdreesi, Shakir A. Bakkari, Othman R. Alharbi, Nahla A. Azzam, Abdulelah Almutairdi, Khalidah A. Alenzi, Bedor A. Al-Omari, Hajer Y. Almudaiheem, Ahmed H. Al-Jedai, Mahmoud H. Mosli. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents. Saudi Journal of Gastroenterology 2024; doi: 10.4103/sjg.sjg_171_24
|
| 25 |
Leonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, Erin Moshier, Steven Naymagon, John Mascarenhas, Thomas Schiano. The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2021; 27(2): 215 doi: 10.1093/ibd/izaa053
|
| 26 |
Otavio Valério de Carvalho, Daniele Mendes Félix, Leila Rodrigues de Mendonça, Catarina Maria Cataldi Sabino de Araújo, Rafael Freitas de Oliveira Franca, Marli Tenório Cordeiro, Abelardo Silva Júnior, Lindomar José Pena. The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6MMPr) effectively blocks Zika virus replication. International Journal of Antimicrobial Agents 2017; 50(6): 718 doi: 10.1016/j.ijantimicag.2017.08.016
|
| 27 |
Xiao-Feng Hou, Hao Pan, Li-Hui Xu, Qing-Bing Zha, Xian-Hui He, Dong-Yun Ouyang. Piperine Suppresses the Expression of CXCL8 in Lipopolysaccharide-Activated SW480 and HT-29 Cells via Downregulating the Mitogen-Activated Protein Kinase Pathways. Inflammation 2015; 38(3): 1093 doi: 10.1007/s10753-014-0075-z
|
| 28 |
Bruce E. Sands, William J. Sandborn, Remo Panaccione, Christopher D. O’Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J. Adedokun, Katherine Li, Laurent Peyrin-Biroulet, Gert Van Assche, Silvio Danese, Stephan Targan, Maria T. Abreu, Tadakazu Hisamatsu, Philippe Szapary, Colleen Marano. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. New England Journal of Medicine 2019; 381(13): 1201 doi: 10.1056/NEJMoa1900750
|
| 29 |
Stacy Chapman, Wael El-Matary. Screening for Epstein–Barr Virus Status and Risk of Hemophagocytic Lymphohistiocytosis in Children With Inflammatory Bowel Disease on Azathioprine. Gastroenterology 2017; 153(4): 1167 doi: 10.1053/j.gastro.2017.07.052
|
| 30 |
Anna Thunström Salzer, Maria J. Niemiec, Ava Hosseinzadeh, Marios Stylianou, Fredrik Åström, Marc Röhm, Clas Ahlm, Anders Wahlin, David Ermert, Constantin F. Urban. Assessment of Neutrophil Chemotaxis Upon G-CSF Treatment of Healthy Stem Cell Donors and in Allogeneic Transplant Recipients. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01968
|
| 31 |
Domenico Corica, Claudio Romano. Renal Involvement in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 2016; 10(2): 226 doi: 10.1093/ecco-jcc/jjv138
|
| 32 |
Jens Vikse, Daniel Limi Cacic, Arne Carlsen, Trond Johan Cooper, Tore Grimstad. En mann i 30-årene med ulcerøs kolitt og pancytopeni. Tidsskrift for Den norske legeforening 2016; 136(11): 1010 doi: 10.4045/tidsskr.15.0958
|
| 33 |
Livia Biancone, Vito Annese, Sandro Ardizzone, Alessandro Armuzzi, Emma Calabrese, Flavio Caprioli, Fabiana Castiglione, Michele Comberlato, Mario Cottone, Silvio Danese, Marco Daperno, Renata D’Incà, Giuseppe Frieri, Walter Fries, Paolo Gionchetti, Anna Kohn, Giovanni Latella, Monica Milla, Ambrogio Orlando, Claudio Papi, Carmelina Petruzziello, Gabriele Riegler, Fernando Rizzello, Simone Saibeni, Maria Lia Scribano, Maurizio Vecchi, Piero Vernia, Gianmichele Meucci, Annalisa Aratari, Fabrizio Bossa, Maria Cappello, Andrea Cassinotti, Alberto Chiriatti, Gionata Fiorino, Vincenzo Formica, Luisa Guidi, Alessandra Losco, Filippo Mocciaro, Sara Onali, Luca Pastorelli, Roberta Pica, Mariabeatrice Principi, Sara Renna, Chiara Ricci, Antonio Rispo, Francesca Rogai, Loredana Sarmati, Franco Scaldaferri, Luisa Spina, Rosy Tambasco, Anna Testa, Angelo Viscido. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Digestive and Liver Disease 2017; 49(4): 338 doi: 10.1016/j.dld.2017.01.141
|
| 34 |
Aviv Pudipeddi, Viraj Kariyawasam, Craig Haifer, Brandon Baraty, Sudarshan Paramsothy, Rupert WL Leong. Safety of drugs used for the treatment of Crohn’s disease. Expert Opinion on Drug Safety 2019; 18(5): 357 doi: 10.1080/14740338.2019.1612874
|
| 35 |
Margret Alm, Viola Andresen, Christian Ell, Christiane Fibbe, Wolfgang Fischbach, Jutta Keller, PH. Frank Kipp, Andrea May, Stephan Miehlke, Rainer Porschen, Andreas Stallmach, Thomas Weinke, Niklas Aehling, Margret Alm, Viola Andresen, Daniel C. Baumgart, Franziska Bertram, Albrecht Böhlig, Catharina Bullmann, Johanna Carstensen, Marie de Greck, Wienke Ellerbeck, Giulia Enders, Christiane Fibbe, Wolfgang Fischbach, Korinna Fritz, Antonia Gaus, Laura Gottschalk, Kai Daniel Grandt, Utah-Maria Henniges, Toni Herta, Dorothea Jasper, Jutta Keller, Nina Kschowak, Konstantin Lang, Alina Lange, Peter Layer, Niels Liedtke, Janek Luttermann, Lida Mancke, Viola Sophie Meier, Ulrike Melle, Daniela Menge, Stefan Michaelis, Sara Nader, Tim-Alexander Niedergassel, Carsten Pachmann, Rainer Porschen, Solveig Rose, Ulrich Rosien, Martin Rössle, Melina Schellhorn, Oliver Schnell, Sebastian Schulz, Julian Siegel, Alexander Stein, Johannes Szuba, Sarah Teising, Stephanie Thiel, Julia Thomas-Morr, Henriette Tillmann, Friederike Todt, Rhea Veelken, Henrike von Schassen, Michael Wölfel, Susanna Wolf, Valentin Wolgast, Clara Wübbolding, Kathrin Zimmermann. Facharztwissen Gastroenterologie und Hepatologie. 2021; : 301 doi: 10.1016/B978-3-437-21252-9.00007-9
|
| 36 |
George A. Stamatiades, Petros Ioannou, George Petrikkos, Constantinos Tsioutis. Fungal infections in patients with inflammatory bowel disease: A systematic review. Mycoses 2018; 61(6): 366 doi: 10.1111/myc.12753
|
| 37 |
Hina Salahuddin, Muhammad Junaid Iqbal Tahir. 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine. 2020; : 413 doi: 10.1007/978-981-15-1067-0_18
|
| 38 |
Rongfang Lin, Weiwei Lin, Changlian Wang, Jiashan Dong, Weiwei Zheng, Dayong Zeng, Yiwei Liu, Cuihong Lin, Zheng Jiao, Pinfang Huang. Population pharmacokinetics of azathioprine active metabolite in patients with inflammatory bowel disease and dosage regimens optimisation. Basic & Clinical Pharmacology & Toxicology 2021; 128(3): 482 doi: 10.1111/bcpt.13530
|
| 39 |
|
| 40 |
Ji Young Chang, Jae Hee Cheon. Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics. Digestive Diseases and Sciences 2019; 64(9): 2395 doi: 10.1007/s10620-019-05720-5
|